ERBB2 and breast carcinoma: A19 binding studies revealed that this antibody recognizes the N-glycan epitope on Erb-b2 (Erb-b2 receptor tyrosine kinase 2) that is expressed by many different breast cancer and ovarian cancer cell lines [62].